Literature DB >> 22548359

A single-centre randomized controlled clinical trial on the adjunct treatment of intra-bony defects with autogenous bone or a xenograft: results after 12 months.

Ahmad Aghazadeh1, G Rutger Persson, Stefan Renvert.   

Abstract

BACKGROUND: Limited evidence exists on the efficacy of regenerative treatment of peri-implantitis.
MATERIAL AND METHODS: Subjects receiving antibiotics and surgical debridement were randomly assigned to placement of autogenous bone (AB) or bovine-derived xenograft (BDX) and with placement of a collagen membrane. The primary outcome was evidence of radiographic bone fill and the secondary outcomes included reductions of probing depth (PD) bleeding on probing (BOP) and suppuration.
RESULTS: Twenty-two subjects were included in the AB and 23 subjects in the BDX group. Statistical analysis failed to demonstrate differences for 38/39 variables assessed at baseline. At 12 months, significant better results were obtained in the BDX group for bone levels (p < 0.001), BOP (p = 0.004), PI (p = 0.003) and suppuration (p < 0.01). When adjusting for number of implants treated per subject, a successful treatment outcome PD ≤ 5.0 mm, no pus, no bone loss and BOP at 1/4 or less sites the likelihood of defect fill was higher in the BDX group (LR: 3.2, 95% CI: 1.0-10.6, p < 0.05).
CONCLUSIONS: Bovine xenograft provided more radiographic bone fill than AB. The success for both surgical regenerative procedures was limited. Decreases in PD, BOP, and suppuration were observed.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22548359     DOI: 10.1111/j.1600-051X.2012.01880.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  21 in total

1.  [Short-term outcome of regenerative surgery treating peri-implantitis].

Authors:  D Shi; J Cao; S A Dai; H X Meng
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-02-18

Review 2.  Reconstructive procedures for treating peri-implantitis: a systematic review.

Authors:  V Khoshkam; H L Chan; G H Lin; M P MacEachern; A Monje; F Suarez; W V Giannobile; H L Wang
Journal:  J Dent Res       Date:  2013-10-24       Impact factor: 6.116

Review 3.  Ceramic and non-ceramic hydroxyapatite as a bone graft material: a brief review.

Authors:  S R Dutta; D Passi; P Singh; A Bhuibhar
Journal:  Ir J Med Sci       Date:  2014-11-27       Impact factor: 1.568

Review 4.  Efficacy of alternative or adjunctive measures to conventional non-surgical and surgical treatment of peri-implant mucositis and peri-implantitis: a systematic review and meta-analysis.

Authors:  Ausra Ramanauskaite; Tobias Fretwurst; Frank Schwarz
Journal:  Int J Implant Dent       Date:  2021-11-15

5.  Comparative, Histological and Histomorphometric Analysis of Three Anorganic Bovine Xenogenous Bone Substitutes: Bio-Oss, Bone-Fill and Gen-Ox Anorganic.

Authors:  Rafael Manfro; Fabiano Silva Fonseca; Marcelo Carlos Bortoluzzi; Wilson Roberto Sendyk
Journal:  J Maxillofac Oral Surg       Date:  2013-08-02

Review 6.  Regenerative Medicine for Periodontal and Peri-implant Diseases.

Authors:  L Larsson; A M Decker; L Nibali; S P Pilipchuk; T Berglundh; W V Giannobile
Journal:  J Dent Res       Date:  2015-11-25       Impact factor: 6.116

7.  Antimicrobial Hydroxyapatite-Gelatin-Silica Composite Pastes with Tunable Setting Properties.

Authors:  Vuk Uskoković; Shreya Ghosh; Victoria M Wu
Journal:  J Mater Chem B       Date:  2017-07-13       Impact factor: 6.331

Review 8.  Definition, etiology, prevention and treatment of peri-implantitis--a review.

Authors:  Ralf Smeets; Anders Henningsen; Ole Jung; Max Heiland; Christian Hammächer; Jamal M Stein
Journal:  Head Face Med       Date:  2014-09-03       Impact factor: 2.151

Review 9.  Management of peri-implantitis: a systematic review, 2010-2015.

Authors:  Nisha Mahato; Xiaohong Wu; Lu Wang
Journal:  Springerplus       Date:  2016-02-01

Review 10.  Treatment Alternatives to Negotiate Peri-Implantitis.

Authors:  Eli E Machtei
Journal:  Adv Med       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.